Pentoxifylline-d5 is a deuterium-labeled version of Pentoxifylline. The unlabeled compound, Pentoxifylline (BL-191), acts as a haemorheological agent and is an orally active, non-selective phosphodiesterase (PDE) inhibitor. It demonstrates immune modulation, anti-inflammatory, hemorheological, anti-fibrinolytic, and anti-proliferation effects. This compound can be utilized in research concerning peripheral vascular disease, cerebrovascular disease, and other conditions involving impaired regional microcirculation.
- Used as a tracer.
- Functions as an internal standard for quantitative analysis through methods like NMR, GC-MS, or LC-MS.
- Stable heavy isotopes are incorporated into drug molecules for quantitation during drug development.
- Deuteration can influence the pharmacokinetic and metabolic profiles of compounds.